Tetratherix Valuation Multiples

Tetratherix Overview

About Tetratherix

Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.

Founded

2015

HQ

Employees

N/A

Website

tetratherix.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $2M

EBITDA: ($7M)

EV

$161M

Valuation Multiples

Multiples.vc

Start free trial

Tetratherix Financials

Tetratherix reported last 12-month revenue of $2M and negative EBITDA of ($7M).

In the same LTM period, Tetratherix generated ($7M) in EBITDA losses and had net loss of ($6M).

Tetratherix P&L

In the most recent fiscal year, Tetratherix reported revenue of — and net income of —.

Tetratherix expects next 12-month revenue of XXX and NTM EBITDA of XXX

Tetratherix Stock Performance

Tetratherix has current market cap of $168M, and enterprise value of $161M.

Tetratherix's stock price is $3.31.

Tetratherix Valuation Multiples

Tetratherix trades at 74.0x EV/Revenue multiple, and (23.2x) EV/EBITDA.

Tetratherix Financial Valuation Multiples

As of April 10, 2026, Tetratherix has market cap of $168M and EV of $161M.

Equity research analysts estimate Tetratherix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Tetratherix has a P/E ratio of (28.2x).

Tetratherix Margins & Growth Rates

Tetratherix's revenue in the last 12 month grew by 33%.

Tetratherix's rule of 40 is (213%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Tetratherix's rule of X is (113%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Tetratherix Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Tetratherix M&A Activity

Tetratherix acquired XXX companies to date.

Last acquisition by Tetratherix was on XXXXXXXX, XXXXX. Tetratherix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Tetratherix Investment Activity

Tetratherix invested in XXX companies to date.

Tetratherix made its latest investment on XXXXXXXX, XXXXX. Tetratherix invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).